580 related articles for article (PubMed ID: 1862693)
41. Lipoprotein composition in patients with type 1 diabetes mellitus: Impact of lipases and adipokines.
Hughes TA; Calderon RM; Diaz S; Mendez AJ; Goldberg RB
J Diabetes Complications; 2016; 30(4):657-68. PubMed ID: 26997169
[TBL] [Abstract][Full Text] [Related]
42. The transport of vitamin E in plasma and its correlation to plasma lipoproteins in non-insulin-dependent diabetes mellitus.
Kökoğlu E; Ulakoğlu E
Diabetes Res Clin Pract; 1991 Dec; 14(3):175-81. PubMed ID: 1778110
[TBL] [Abstract][Full Text] [Related]
43. Lipoprotein Subfractions and Glucose Homeostasis in Prediabetes and Diabetes in Taiwan.
Hsu H; Hsu P; Cheng MH; Ito Y; Kanda E; Schaefer EJ; Ai M
J Atheroscler Thromb; 2019 Oct; 26(10):890-914. PubMed ID: 30726792
[TBL] [Abstract][Full Text] [Related]
44. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
[TBL] [Abstract][Full Text] [Related]
45. Apolipoprotein and lipid ratios in treated non-insulin dependent diabetics.
Dean JD; Owens DR; Matthews SB
Diabetes Res; 1990 Sep; 15(1):21-5. PubMed ID: 2132196
[TBL] [Abstract][Full Text] [Related]
46. Postprandial amplification of lipoprotein abnormalities in controlled type II diabetic subjects: relationship to postprandial lipemia and C-peptide/glucagon levels.
Cavallero E; Dachet C; Neufcour D; Wirquin E; Mathe D; Jacotot B
Metabolism; 1994 Mar; 43(3):270-8. PubMed ID: 8139473
[TBL] [Abstract][Full Text] [Related]
47. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
[TBL] [Abstract][Full Text] [Related]
48. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy.
Eirís J; Novo-Rodríguez MI; Del Río M; Meseguer P; Del Río MC; Castro-Gago M
Epilepsy Res; 2000 Aug; 41(1):1-7. PubMed ID: 10924863
[TBL] [Abstract][Full Text] [Related]
49. Effect of fish oil concentrate on lipoprotein composition in NIDDM.
Schectman G; Kaul S; Kissebah AH
Diabetes; 1988 Nov; 37(11):1567-73. PubMed ID: 3181646
[TBL] [Abstract][Full Text] [Related]
50. Hormonal contraception in women with IDDM. Influence on glycometabolic control and lipoprotein metabolism.
Petersen KR; Skouby SO; Vedel P; Haaber AB
Diabetes Care; 1995 Jun; 18(6):800-6. PubMed ID: 7555506
[TBL] [Abstract][Full Text] [Related]
51. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins.
Vaverková H; Chlup R; Ficker L; Novotny D; Bartek J
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():74-7. PubMed ID: 9288551
[TBL] [Abstract][Full Text] [Related]
52. Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease.
Bakogianni MC; Kalofoutis CA; Skenderi KI; Kalofoutis AT
J Diabetes Complications; 2001; 15(5):265-9. PubMed ID: 11522502
[TBL] [Abstract][Full Text] [Related]
53. Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?
Romano G; Patti L; Innelli F; Di Marino L; Annuzzi G; Iavicoli M; Coronel GA; Riccardi G; Rivellese AA
Diabetes; 1997 Oct; 46(10):1601-6. PubMed ID: 9313756
[TBL] [Abstract][Full Text] [Related]
54. Diabetes and plasma lipoproteins in Native Americans. Studies of the Pima Indians.
Howard BV
Diabetes Care; 1993 Jan; 16(1):284-91. PubMed ID: 8422793
[TBL] [Abstract][Full Text] [Related]
55. Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia.
Stewart MW; Laker MF; Dyer RG; Game F; Mitcheson J; Winocour PH; Alberti KG
Arterioscler Thromb; 1993 Jul; 13(7):1046-52. PubMed ID: 8318506
[TBL] [Abstract][Full Text] [Related]
56. Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM.
Abate N; Vega GL; Garg A; Grundy SM
Atherosclerosis; 1995 Nov; 118(1):111-22. PubMed ID: 8579621
[TBL] [Abstract][Full Text] [Related]
57. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
Artery; 1993; 20(1):1-18. PubMed ID: 8447724
[TBL] [Abstract][Full Text] [Related]
58. Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy.
Kahri J; Groop PH; Elliott T; Viberti G; Taskinen MR
Diabetes Care; 1994 May; 17(5):412-9. PubMed ID: 8062608
[TBL] [Abstract][Full Text] [Related]
59. Changes in high density lipoprotein subfraction lipids during neutral lipid transfer in healthy subjects and in patients with insulin-dependent diabetes mellitus.
Ritter MC; Bagdade JD
Lipids; 1996 Jan; 31(1):1-7. PubMed ID: 8649226
[TBL] [Abstract][Full Text] [Related]
60. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Brunner D
Clin Ther; 1988; 10(4):392-400. PubMed ID: 3152618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
